| Molecular mechanisms of action of genistein in cancer: Recent advances HS Tuli, MJ Tuorkey, F Thakral, K Sak, M Kumar, AK Sharma, U Sharma, ... Frontiers in Pharmacology 10, 489844, 2019 | 292 | 2019 |
| SNHG12: an LncRNA as a potential therapeutic target and biomarker for human cancer S Tamang, V Acharya, D Roy, R Sharma, A Aryaa, U Sharma, ... Frontiers in oncology 9, 901, 2019 | 124 | 2019 |
| Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer U Sharma, TS Barwal, A Malhotra, N Pant, D Dey, A Gautam, HS Tuli, ... Life sciences 257, 118035, 2020 | 53 | 2020 |
| Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy A Malhotra, U Sharma, S Puhan, NC Bandari, A Kharb, PP Arifa, L Thakur, ... Biochimie 156, 148-157, 2019 | 35 | 2019 |
| Circulating miR-320a acts as a tumor suppressor and prognostic factor in non-small cell lung cancer A Khandelwal, U Sharma, TS Barwal, RK Seam, M Gupta, MK Rana, ... Frontiers in Oncology 11, 645475, 2021 | 33 | 2021 |
| LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3 U Sharma, TS Barwal, A Khandelwal, A Malhotra, MK Rana, APS Rana, ... Biochimie 182, 99-107, 2021 | 33 | 2021 |
| Cancer susceptibility candidate 9 (CASC9): a novel targetable long noncoding RNA in cancer treatment U Sharma, TS Barwal, V Acharya, S Tamang, KM Vasquez, A Jain Translational oncology 13 (8), 100774, 2020 | 32 | 2020 |
| Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection HS Tuli, VK Garg, S Bhushan, V Uttam, U Sharma, A Jain, K Sak, V Yadav, ... Translational Oncology 27, 101596, 2023 | 31 | 2023 |
| Macrophage activation syndrome and COVID 19: impact of MAPK driven immune-epigenetic programming by SARS-Cov-2 RK Roy, U Sharma, MK Wasson, A Jain, MI Hassan, H Prakash Frontiers in immunology 12, 763313, 2021 | 23 | 2021 |
| NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target V Aggarwal, HS Tuli, M Varol, M Tuorkey, K Sak, NC Parashar, TS Barwal, ... Critical Reviews in Oncology/Hematology 164, 103403, 2021 | 23 | 2021 |
| A panel of circulating long non-coding RNAs as liquid biopsy biomarkers for breast and cervical cancers TS Barwal, U Sharma, KM Vasquez, H Prakash, A Jain Biochimie 176, 62-70, 2020 | 23 | 2020 |
| Role of Hedgehog and Hippo signaling pathways in cancer: a special focus on non-coding RNAs U Sharma, HS Tuli, V Uttam, R Choudhary, B Sharma, U Sharma, ... Pharmacological Research 186, 106523, 2022 | 20 | 2022 |
| STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation HS Tuli, K Sak, A Iqubal, VK Garg, M Varol, U Sharma, A Chauhan, ... Molecular Biology Reports 49 (9), 8987-8999, 2022 | 14 | 2022 |
| Long non-coding RNAs as strategic molecules to augment the radiation therapy in esophageal squamous cell carcinoma U Sharma, TS Barwal, V Acharya, K Singh, MK Rana, SK Singh, ... International Journal of Molecular Sciences 21 (18), 6787, 2020 | 14 | 2020 |
| MicroRNAs and long noncoding RNAs as novel therapeutic targets in estrogen receptor-positive breast and ovarian cancers TS Barwal, U Sharma, S Bazala, I Singh, M Jain, H Prakash, S Shekhar, ... International Journal of Molecular Sciences 22 (8), 4072, 2021 | 12 | 2021 |
| Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advances A Hussain, A Kumar, V Uttam, U Sharma, K Sak, RV Saini, AK Saini, ... Environmental Research, 116476, 2023 | 11 | 2023 |
| Circulating long non-coding RNAs LINC00324 and LOC100507053 as potential liquid biopsy markers for esophageal squamous cell carcinoma: a pilot study U Sharma, TS Barwal, A Khandelwal, MK Rana, APS Rana, K Singh, ... Frontiers in Oncology 12, 823953, 2022 | 11 | 2022 |
| Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets HS Tuli, K Sak, S Adhikary, G Kaur, D Aggarwal, J Kaur, M Kumar, ... Experimental Biology and Medicine 247 (4), 345-359, 2022 | 10 | 2022 |
| Significant structural change in human c-Myc promoter G-quadruplex upon peptide binding in potassium N Kundu, T Sharma, S Kaur, M Singh, V Kumar, U Sharma, A Jain, ... RSC advances 12 (13), 7594-7604, 2022 | 10 | 2022 |
| Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever RK Roy, R Yadav, U Sharma, MK Wasson, A Sharma, P Tanwar, A Jain, ... International Journal of Cancer 151 (7), 981-992, 2022 | 8 | 2022 |
Akshay MalhotraFreie Universität在 zedat.fu-berlin.de 的电子邮件经过验证
Akshay MalhotraFreie Universität在 zedat.fu-berlin.de 的电子邮件经过验证